Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit

$HIMSPress releaseOct 2, 2026, 3:40 PM ETRead the release

Rosen Law Firm issued a shareholder-solicitation notice reminding HIMS purchasers between August 4, 2025 and July 29, 2026 of a November 2, 2026 lead plaintiff deadline. The underlying class action alleges Hims & Hers failed to disclose sharing consumer health data with third-party advertising platforms and charging for prescriptions before medical consultations, creating regulatory exposure.

Key figures

Class period end
2026-07-29
Class period start
2025-08-04
Lead plaintiff deadline
2026-11-02

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.